$0.307
+0.001 (+0.20%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
OLB Prediction & Forecast by Similar Chart Analysis
Alphio's OLB stock price prediction model matches the current OLB Group Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.30 (-1.09%). The 1-week path is $0.31 (+1.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy OLB Group Inc Stock?
Currently, OLB Group Inc is not a strong buy due to its ongoing financial struggles, despite a slight recent uptick in stock price. The current price is $0.31, and the stock has seen a 5-day change of +3.09%. However, it has a year-to-date change of -52.87%, indicating significant volatility and risk. The RSI is at 51.79, suggesting a neutral momentum, while the forward P/E ratio is 0, indicating no expected earnings growth in the near term. The main risk is the net income loss, which was -$1,054,806 in the latest quarter, reflecting ongoing financial challenges that could hinder recovery.
OLB stock price ended at $0.31 on Friday, after rising +0.20%
OLB Group Inc (OLB) last closed at $0.3066, gaining +0.20%. These facts feed the 1-day and 1-week OLB price prediction above.
Forecast Drivers
OLB Group Inc (OLB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches OLB, ranked by similarity.
Seasonality analysis for OLB
Historically the probability of a positive August return for OLB is 0.00%. June offers the highest probability of a positive month at 18.33%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.